Source:http://linkedlifedata.com/resource/pubmed/id/18597894
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
2008-9-22
|
pubmed:abstractText |
We have recently identified a specific binding site for the tachykinin peptide substance P (SP) fragment SP(1-7) in the rat spinal cord. This site appeared very specific for SP(1-7) as the binding affinity of this compound highly exceeded those of other SP fragments. We also observed that endomorphin-2 (EM-2) exhibited high potency in displacing SP(1-7) from this site. In the present work using a [(3)H]-labeled derivative of the heptapeptide we have identified and characterized [(3)H]-SP(1-7) binding in the rat ventral tegmental area (VTA). Similarly to the [(3)H]-SP(1-7) binding in the spinal cord the affinity of unlabeled SP(1-7) to the specific site in VTA was significantly higher than those of other SP fragments. Further, the tachykinin receptor NK-1, NK-2 and NK-3 ligands showed no or negligible binding to the identified site. However, the mu-opioid peptide (MOP) receptor agonists DAMGO, EM-1 and EM-2 did, and significant difference was observed in the binding affinity between the two endomorphins. As recorded from displacement curves the affinity of EM-2 for the SP(1-7) site was 4-5 times weaker than that for SP(1-7) but about 5 times higher than that of EM-1. The opioid receptor antagonists naloxone and naloxonazine showed weak or negligible binding. It was concluded that the specific site identified for SP(1-7) binding in the rat VTA is distinct from the MOP receptor although it exhibits high affinity for EM-2.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Analgesics, Opioid,
http://linkedlifedata.com/resource/pubmed/chemical/Oligopeptides,
http://linkedlifedata.com/resource/pubmed/chemical/Peptide Fragments,
http://linkedlifedata.com/resource/pubmed/chemical/Substance P,
http://linkedlifedata.com/resource/pubmed/chemical/endomorphin 1,
http://linkedlifedata.com/resource/pubmed/chemical/endomorphin 2,
http://linkedlifedata.com/resource/pubmed/chemical/substance P (1-7)
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0196-9781
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
29
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1820-4
|
pubmed:meshHeading |
pubmed-meshheading:18597894-Analgesics, Opioid,
pubmed-meshheading:18597894-Animals,
pubmed-meshheading:18597894-Binding Sites,
pubmed-meshheading:18597894-Male,
pubmed-meshheading:18597894-Oligopeptides,
pubmed-meshheading:18597894-Peptide Fragments,
pubmed-meshheading:18597894-Protein Binding,
pubmed-meshheading:18597894-Rats,
pubmed-meshheading:18597894-Rats, Sprague-Dawley,
pubmed-meshheading:18597894-Substance P,
pubmed-meshheading:18597894-Ventral Tegmental Area
|
pubmed:year |
2008
|
pubmed:articleTitle |
Endomorphins interact with the substance P (SP) aminoterminal SP(1-7) binding in the ventral tegmental area of the rat brain.
|
pubmed:affiliation |
Department of Pharmaceutical Biosciences, Uppsala University, SE-751 24 Uppsala, Sweden.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|